<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
   
                                   FORM 10-KSB/A
    
(Mark One)

[X]      Annual report pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 [Fee Required] for the fiscal year ended June 30,
         1996 or

[ ]      Transition report pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 [No Fee Required] for the transition period from
         ______________to______________


                         Commission file number 33-93132

                           LA JOLLA DIAGNOSTICS, INC.
                 [Name of small business issuer in its charter]

<TABLE>
<S>                                                   <C>
                   California                                     94-2901715
        (State or other jurisdiction of               (I.R.S. Employer Identification No.)
         incorporation or organization)                              92037
 7777 Fay Avenue, Suite 160, La Jolla, California                  (Zip Code)
    (Address of principal executive office)
</TABLE>

        Registrant's telephone number including area code: (619) 454-6790

           Securities registered pursuant to Section 12(b) of the Act:
                                      None
             Securities registered pursuant to Section 12(g) of Act:
                           Common Stock, No Par Value
                                (Title of Class)

         Check whether this issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities exchange Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days.  Yes      [X]      No       [ ]

         Check if there is no disclosure of delinquent filers in response to
item 405 of Regulation S-B contained herein, and no disclosure will be
contained, to the best of the registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB.           [X]

         The issuer's revenues for its most recent fiscal year were $143,977.

         The aggregate market value of the voting stock held by non-affiliates
computed by reference to the price at which the stock was last sold by the
registrant outstanding as of June 30, 1996 was $1,923,677.

         The number of shares of the Common Stock of the registrant outstanding
as of June 30, 1996 was 7,576,175.

         Documents incorporated by reference and parts of Form 10-KSB into which
incorporated: One.

    Transitional Small Business Disclosure Format (check one): Yes [ ] No [X]
THIS REPORT INCLUDES A TOTAL OF 42 PAGES. THE EXHIBIT INDEX APPEARS ON PAGE 41.
<PAGE>   2
SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934,
the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.


Date:  October 14, 1996                    LA JOLLA DIAGNOSTICS, INC.


                                           By: /s/ DON BRUCKER
                                              __________________________________
                                              Don Brucker
                                              President, Chief Executive Officer


                  In accordance with the Exchange Act of 1934, this report has
been signed below by the following persons on behalf of the registrant and in
the capacities and on the date indicated.

<TABLE>
<CAPTION>
                                         Title                                 Date
<S>                                   <C>                                     <C>

/s/ DON BRUCKER
__________________________            Director, President, Chief Executive     October 14, 1996
Don Brucker                           Officer and Chief Financial Officer
                                      (Principal Executive Officer, Principal
                                      Financial Officer and Controller)

   
/s/ ROBERT HAMBURGER, M.D.
__________________________            Director and Secretary                   October 14, 1996
Robert Hamburger, M.D.
    


/s/ STANLEY V. HEYMAN
__________________________            Director                                 October 14, 1996
Stanley V. Heyman


   
/s/ RICHARD O'CONNOR, M.D.
__________________________            Director                                 October 14, 1996
Richard O'Connor, M.D.
    
</TABLE>


                                       42